亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Summary of the clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults.

创伤后应激 指南 心理学 临床心理学 精神科 心理干预 眼动脱敏与再处理 循证实践 帕罗西汀 医学 心理治疗师 替代医学 焦虑 病理 抗抑郁药
出处
期刊:American Psychologist [American Psychological Association]
卷期号:74 (5): 596-607 被引量:56
标识
DOI:10.1037/amp0000473
摘要

The American Psychological Association (APA) developed a clinical practice guideline (CPG) to provide recommendations on psychological and pharmacological treatments for posttraumatic stress disorder (PTSD) in adults. This paper is a summary of the CPG, including the development process. Members of the guideline development panel (GDP) used a comprehensive systematic review conducted by the Research Triangle Institute-University of North Carolina Evidence-based Practice Center (RTI-UNC EPC) as its primary evidence base (Jonas et al., 2013). The GDP consisted of health professionals from psychology, psychiatry, social work, and family medicine as well as community members who self-identified as having had PTSD. PTSD symptom reduction and serious harms were selected by the GDP as critical outcomes for making recommendations. The GDP strongly recommends use of the following psychotherapies/interventions (in alphabetical order) for adults with PTSD: cognitive-behavioral therapy, cognitive processing therapy, cognitive therapy, and prolonged exposure therapy. The GDP conditionally recommends the use of brief eclectic psychotherapy, eye movement desensitization and reprocessing (EMDR), and narrative exposure therapy (NET). For medications, the GDP conditionally recommends the following (in alphabetical order): fluoxetine, paroxetine, sertraline, and venlafaxine. There is insufficient evidence to recommend for or against offering Seeking Safety, relaxation, risperidone, and topiramate. A subgroup of the GDP reviewed studies published after the systematic review for those treatments that received substantive recommendations; the GDP concluded that future systematic reviews that incorporated those new studies could change the recommendations for EMDR and NET from conditional to strong. For all other treatments, results of the update indicated that recommendations were unlikely to change or that there were no new trials for comparison. The target audience for this CPG includes clinicians, researchers, patients, and policymakers. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
36秒前
白云朵儿发布了新的文献求助10
41秒前
53秒前
白云朵儿发布了新的文献求助10
1分钟前
wanwan47发布了新的文献求助30
1分钟前
2分钟前
心灵美诗霜完成签到 ,获得积分10
2分钟前
wodetaiyangLLL完成签到 ,获得积分10
2分钟前
lixuebin完成签到 ,获得积分10
3分钟前
七七发布了新的文献求助10
3分钟前
大个应助科研通管家采纳,获得10
3分钟前
白云朵儿发布了新的文献求助10
3分钟前
3分钟前
Orange应助七七采纳,获得10
4分钟前
酷波er应助guan采纳,获得10
4分钟前
CodeCraft应助wanwan47采纳,获得10
4分钟前
wanwan47完成签到,获得积分10
5分钟前
ruba发布了新的文献求助10
5分钟前
5分钟前
老弍发布了新的文献求助10
5分钟前
ruba关注了科研通微信公众号
5分钟前
6分钟前
6分钟前
白云朵儿发布了新的文献求助10
6分钟前
6分钟前
guan发布了新的文献求助10
6分钟前
6分钟前
老弍发布了新的文献求助10
6分钟前
guan完成签到,获得积分20
6分钟前
6分钟前
连安阳发布了新的文献求助10
7分钟前
Ann完成签到,获得积分10
7分钟前
7分钟前
白云朵儿发布了新的文献求助10
8分钟前
wangfaqing942完成签到 ,获得积分10
9分钟前
FashionBoy应助zhao123123采纳,获得30
9分钟前
10分钟前
zhao123123发布了新的文献求助30
10分钟前
明理的夜蓉完成签到 ,获得积分10
10分钟前
10分钟前
高分求助中
Un calendrier babylonien des travaux, des signes et des mois: Séries iqqur îpuš 1036
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 1000
Corrosion and Oxygen Control 600
Heterocyclic Stilbene and Bibenzyl Derivatives in Liverworts: Distribution, Structures, Total Synthesis and Biological Activity 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
行動データの計算論モデリング 強化学習モデルを例として 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2545629
求助须知:如何正确求助?哪些是违规求助? 2175642
关于积分的说明 5600192
捐赠科研通 1896371
什么是DOI,文献DOI怎么找? 946248
版权声明 565371
科研通“疑难数据库(出版商)”最低求助积分说明 503557